Detalhe da pesquisa
1.
Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study.
J Natl Compr Canc Netw
; : 1-9, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744306
2.
Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients.
BMC Womens Health
; 24(1): 187, 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38509531
3.
Prevalence, treatment patterns, and prognosis of low estrogen receptor-positive (1% to 10%) breast cancer: a single institution's experience in Korea.
Breast Cancer Res Treat
; 189(3): 653-663, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34487293
4.
The efficacy and safety of indocyanine green-hyaluronic acid mixture (LuminoMark™) for localization in patients with non-palpable breast lesions: a multi-center open-label parallel phase-2 clinical trial.
BMC Surg
; 21(1): 134, 2021 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33726718
5.
Correction to: ECM1 regulates cell proliferation and trastuzumab resistance through activation of EGF-signaling.
Breast Cancer Res
; 21(1): 45, 2019 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30914052
6.
A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients.
Breast Cancer Res Treat
; 173(2): 255-266, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30324273
7.
Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?
Breast Cancer Res Treat
; 173(1): 189-199, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30238275
8.
Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South Korea.
BMC Cancer
; 19(1): 84, 2019 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30654765
9.
Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort.
Breast Cancer Res Treat
; 171(3): 737-745, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29931426
10.
Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype.
Oncology
; 95(3): 163-169, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29913459
11.
Radiation-related heart disease after breast cancer radiation therapy in Korean women.
Breast Cancer Res Treat
; 166(1): 249-257, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28717853
12.
Identification of ganglioside GM2 activator playing a role in cancer cell migration through proteomic analysis of breast cancer secretomes.
Cancer Sci
; 107(6): 828-35, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27002480
13.
Patient reporting pain intensity immediately after surgery can be associated with underlying depression in women with breast cancer.
Psychooncology
; 25(3): 308-15, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26243455
14.
Cytoplasmic expression of high mobility group B1 (HMGB1) is associated with tumor-infiltrating lymphocytes (TILs) in breast cancer.
Pathol Int
; 66(4): 202-9, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26922571
15.
Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes.
Breast Cancer Res
; 17: 64, 2015 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25935404
16.
Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes.
Breast Cancer Res Treat
; 151(3): 619-27, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26006068
17.
Correlations between molecular subtypes and pathologic response patterns of breast cancers after neoadjuvant chemotherapy.
Ann Surg Oncol
; 22(2): 392-400, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25192679
18.
Expression of NY-ESO-1 in Triple-Negative Breast Cancer Is Associated with Tumor-Infiltrating Lymphocytes and a Good Prognosis.
Oncology
; 89(6): 337-44, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26413775
19.
Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signaling.
Breast Cancer Res
; 16(6): 479, 2014 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25499743
20.
Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer.
Breast Cancer Res Treat
; 145(3): 615-23, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24820412